|1.||Li, Jin: 1 article (02/2011)|
|2.||Lei, Hai-min: 1 article (02/2011)|
|3.||Gao, Rong: 1 article (02/2011)|
|4.||Chi, Shu-ping: 1 article (02/2011)|
|5.||Cheng, Yun: 1 article (02/2011)|
|6.||You, Li-yue: 1 article (02/2011)|
|7.||Wang, Chen: 1 article (02/2011)|
|8.||Kobori, T: 1 article (05/2001)|
|9.||Yamamoto, R: 1 article (05/2001)|
|10.||Matsuyama, M: 1 article (05/2001)|
02/01/2011 - "To study the anti-tumor mechanisms of ascidiacea analog SC002. "
02/01/2011 - "Primary study and anti-tumor mechanisms of analog from SC002."
02/01/2011 - "Ascidiacea analog SC002 can obviously induce the expression of P53, while decreasing the expression of Bcl-2 and VEGF, but have on effect on p21 in tumor tissue; ELISA shown that SC002 can also reduce the concentration of serum VEGF in tumor bearing mice, but did not affected the activity of Caspase-3, 8 and 9. SC002 have the anti-tumor function through promoting the expression of tumor suppressor gene p53, supress the expression of Bcl-2 and VEGF. "
02/01/2011 - "After treated the tumor cells with ascidiacea analog SC002, the changes of a serials of tumor associated cell signal molecules, including VEGF (vascular endothelial growth factor), P53, P21 and Bcl-2 et al, were detected by Western blot; further more the expression of serum VEGF in tumor-bearing mice and the activity of Caspase-3, 8, 9 in tumor tissue were investigated by ELISA; at last. "
|3.||Caspase 3 (Caspase-3)
|4.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)